Top 3 Health Care Stocks That May Explode This Month
Top 3 Health Care Stocks That May Explode This Month
本月可能爆發的前三家醫療保健股票
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
醫療保健領域超賣次數最多的股票爲買入被低估的公司提供了機會。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
RSI是一個動量指標，它比較股票在價格上漲的日子裏的走強與價格下跌的日子的走強。與股票的價格走勢相比，它可以讓交易者更好地了解股票在短期內的表現。根據Benzinga Pro的數據，當相對強弱指數低於30時，資產通常被視爲超賣。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是該行業主要超賣參與者的最新名單，RSI接近或低於30。
Progyny Inc (NASDAQ:PGNY)
Progyny Inc（納斯達克股票代碼：PGNY）
- On Sept. 19, the company said a client elected to exercise an option to terminate its services agreement with the company. The company's stock fell around 32% over the past five days and has a 52-week low of $13.93.
- RSI Value: 26.50
- PGNY Price Action: Shares of Progyny rose 1% to close at $16.62 on Friday.
- Benzinga Pro's real-time newsfeed alerted to latest PGNY news.
- 9月19日，該公司表示，一位客戶選擇行使終止與該公司的服務協議的選擇權。該公司的股票在過去五天中下跌了約32％，跌至52周低點13.93美元。
- RSI 值：26.50
- PGNY價格走勢：週五，Progyny的股價上漲了1％，收於16.62美元。
- Benzinga Pro的實時新聞提醒了最新的PGNY新聞。
Indivior PLC (NASDAQ:INDV)
Indivior PLC（納斯達克股票代碼：INDV）
- On Sept. 4, Indivior issued an update on Aelis Farma's Phase 2B study with AEF0117 in participants with cannabis use disorder. It has a 52-week low of $9.14.
- RSI Value: 25.92
- RELI Price Action: Shares of Indivior fell 2.1% to close at $9.48 on Friday.
- Benzinga Pro's charting tool helped identify the trend in INDV stock.
- 9月4日，Indivior發佈了Aelis Farma針對大麻使用障礙參與者進行的 AEF0117 第20期研究的最新情況。它的52周低點爲9.14美元。
- RSI 值：25.92
- RELI價格走勢：週五，Indivior的股價下跌2.1％，收於9.48美元。
- Benzinga Pro的圖表工具幫助確定了INDV股票的走勢。
Moderna Inc (NASDAQ:MRNA)
摩德納公司（納斯達克股票代碼：MRNA）
- On Sept. 17, Moderna announced that Health Canada approved its vaccine, SPIKEVAX, which aids in preventing COVID-19 in people six months of age or older.The vaccine targets the KP.2 variant of COVID-19. The company plans to begin delivery of the vaccine to the Public Health Agency of Canada shortly. "With the recent increase in COVID-19-infections, staying up to date with your COVID-19 vaccination remains one of the best ways to help protect yourself from severe illness," said Dr. Shehzad Iqbal, country medical director, Moderna Canada. The company's shares fell around 20% over the past month and has a 52-week low of $62.55.
- RSI Value: 28.17
- MRNA Price Action: Shares of Moderna fell 3.4% to close at $65.69 on Friday.
- Benzinga Pro's signals feature notified of a potential breakout in MRNA shares.
- 9月17日，Moderna宣佈，加拿大衛生部批准了其疫苗SPIKEVAX，該疫苗有助於在六個月或以上的人群中預防 COVID-19。該疫苗的目標是 COVID-19 的 KP.2 變體。該公司計劃很快開始向加拿大公共衛生局交付疫苗。加拿大摩德納國家醫學董事謝扎德·伊克巴爾博士說：「隨着最近COVID-19感染人數的增加，及時接種 COVID-19 疫苗仍然是幫助保護自己免受嚴重疾病侵害的最佳方法之一。」該公司的股價在過去一個月中下跌了約20％，跌至52周低點62.55美元。
- RSI 值：28.17
- MRNA價格走勢：週五，摩德納股價下跌3.4％，收於65.69美元。
- Benzinga Pro的信號功能被告知MRNA股票可能出現突破。
- Jim Cramer: Viking Has 'Many Ships Coming In'
- 吉姆·克萊默：維京有 「很多船要進來」